List view / Grid view
13 July 2015 | By Victoria White
Probiodrug is to provide funding to further investigate the potential of pGlu-Abeta antibodies for passive vaccination against Alzheimer's disease...
10 July 2015 | By Victoria White
Effimune has started its Phase I clinical evaluation of FR104, its drug candidate in the immune system regulation control...
10 July 2015 | By Victoria White
Regen BioPharma has reported the successful dosing of mice lacking an immune system in a safety and tolerability study with HemaXellerate...
10 July 2015 | By Victoria White
apceth is to partner with the University of Cologne to combine technologies and expertise, on the development of immunotherapies for solid tumours...
9 July 2015 | By Victoria White
Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered a common cause of heart damage in patients with sepsis...
9 July 2015 | By Victoria White
AstraZeneca and EvoRx have successfully completed a one-year research collaboration using EvoRx's Evo-Link technology to discover cell penetrating peptides...
9 July 2015 | By Victoria White
Epizyme has amended and restated its agreement with Celgene to extend their research collaboration for at least three additional years...
9 July 2015 | By Victoria White
Scientists have shown that didehydro-Cortistatin A reduces residual levels of HIV virus from dormant cells, establishing a near-permanent state of latency...
9 July 2015 | By Victoria White
The transfer of PHE's clinical drug development and production capability into Porton Biopharma Ltd has been approved by the Secretary of State for Health...
8 July 2015 | By Victoria White
Two teams of researchers have discovered a molecule that may favour the production of induced pluripotent stem cells (iPS cells)...
8 July 2015 | By Victoria White
Pfizer’s Centres for Therapeutic Innovation and the Jeffrey Modell Foundation are to collaborate to conduct research in the field of immunological diseases...
8 July 2015 | By Oxford Global
Oxford Global Conferences are proud to present the Cell & Gene Therapy with our co-located 2nd Annual Stem Cell Congress is taking place on the 9th & 10th of November in London, UK...
8 July 2015 | By Victoria White
Douglas Scientific is sponsoring a Tumor Cell Profiling Study for up to three researchers as part of a collaborative partnership with TATAA Biocenter...
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
7 July 2015 | By Victoria White
FY26, a drug able to shut down a cancer cell by exploiting weaknesses inherent in their energy generation, is 49 times more potent than Cisplatin...
